Author:
Wolf Pérez Adriana-Michelle,Lorenzen Nikolai,Vendruscolo Michele,Sormanni Pietro
Reference276 articles.
1. Kaplon H, Muralidharan M, Schneider Z, Reichert JM (2020) Antibodies to watch in 2020. mAbs 12:1703531
2. Hernandez I, Bott SW, Patel AS, Wolf CG, Hospodar AR, Sampathkumar S, Shrank WH (2018) Pricing of monoclonal antibody therapies: higher if used for cancer? Am J Manag Care 24:109–112
3. Jarasch A, Koll H, Regula JT, Bader M, Papadimitriou A, Kettenberger H (2015) Developability assessment during the selection of novel therapeutic antibodies. J Pharm Sci 104:1885–1898
4. Igawa T, Ishii S, Tachibana T, Maeda A, Higuchi Y, Shimaoka S, Moriyama C, Watanabe T, Takubo R, Doi Y, Wakabayashi T, Hayasaka A, Kadono S, Miyazaki T, Haraya K, Sekimori Y, Kojima T, Nabuchi Y, Aso Y, Kawabe Y, Hattori K (2010) Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization. Nat Biotechnol 28:1203–1207
5. Rabia LA, Desai AA, Jhajj HS, Tessier PM (2018) Understanding and overcoming trade-offs between antibody affinity, specificity, stability and solubility. Biochem Eng J 137:365–374
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献